Fulcrum Therapeutics, Inc.

Q4 2021 13F Holders

Symbol: FULC
CUSIP: 359616109
Type: Equity
Class: COM
Num filings: 123
Total reported value, excl. options: $662 M

Compare 2021 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type